|Articles|March 1, 2000

March 2000
Volume 6
Issue 3

An Economic Evaluation of Levofloxacin Versus Cefuroxime Axetil in the Outpatient Treatment of Adults with Community-Acquired Pneumonia

Author(s)Brian E. Rittenhouse, PhD, Aaron A. Stinnett, PhD, Brian Dulisse, PhD

Download PDF: An Economic Evaluation of Levofloxacin Versus Cefuroxime Axetil in the Outpatient Treatment of Adults with Community-Acquired Pneumonia

Articles in this issue

almost 26 years ago

Article

Cost and Quality under Managed Care: Irreconcilable Differences?

almost 26 years ago

Article

Factors Influencing Use of the Prostate-Specific Antigen Screening Test in Primary Care

almost 26 years ago

Article

Utilization and Effectiveness of a Weight-Based Heparin Nomogram at a Large Academic Medical Center

almost 26 years ago

Article

Opportunities and Challenges in Medicaid Managed Care: The Experience in Maryland

almost 26 years ago

Article

Healthcare Utilization among Hispanics: Findings from the 1994 Minority Health Survey

almost 26 years ago

Article

The Association between Pharmacy Closures and Prescription Drug Use: A Retrospective Analysis of Medicaid Prescription Claims in Iowa

almost 26 years ago

Article

The Cost of Productivity Losses Associated with Allergic Rhinitis

almost 26 years ago

Article

Current Concepts in the Management of Smoking Cessation: A Review

almost 26 years ago

Article

The Critical Role of Management in the Delivery of Healthcare Services

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Subjective and Objective Impacts of Ambulatory AI Scribes

ByJulia Adler-Milstein, PhD,Orianna DeMasi, PhD,Hossein Soleimani, PhD,Sarah Beck, MDiv,Maria E. Byron, MD,Aris Oates, MD,Robert Thombley, BS,Jinoos Yazdany, MD, MPH,Sara G. Murray, MD, MAS

January 8th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

An Economic Evaluation of Levofloxacin Versus Cefuroxime Axetil in the Outpatient Treatment of Adults with Community-Acquired Pneumonia

Articles in this issue

Newsletter

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Subjective and Objective Impacts of Ambulatory AI Scribes

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma

Novel CLL Therapies Prompt New Treatment Considerations

Congress Unveils Massive Funding Bill to Avert Shutdown

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD